Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)

Cross-sectional Study of Inflammatory Bowel Disease Severity and Treatment Patterns in Eastern Europe, Middle East, and North Africa. (P08166)

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01293656

Enrollment

Registered

2011-02-10

Start date

2011-08-31

Completion date

2012-07-31

Last updated

2015-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease, Inflammatory Bowel Disease, Ulcerative Colitis

Brief summary

This study is being done to assess the clinical course and treatment options for Crohn's Disease (CD) and ulcerative colitis (UC) in the populations of Eastern Europe, Middle East, and North Africa.

Interventions

OTHERNo intervention.

There is no study intervention. Participants will be treated locally per site standards.

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Confirmed diagnosis of Crohn's disease or ulcerative colitis.

Design outcomes

Primary

Measure	Time frame
The number of participants with Crohn's Disease (CD) or ulcerative colitis (UC) who visit the participating sites.	1 Year
The number of participants with different degrees of CD and UC severity.	1 Year
Use rates of classes of drug therapy.	1 Year
Number and types of surgical interventions.	1 Year
Outcomes of surgical intervention.	1 Year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026